These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1480732)

  • 21. Filgrastim treatment of three patients with clozapine-induced agranulocytosis.
    Lamberti JS; Bellnier TJ; Schwarzkopf SB; Schneider E
    J Clin Psychiatry; 1995 Jun; 56(6):256-9. PubMed ID: 7539786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
    Meged S; Stein D; Sitrota P; Melamed Y; Elizur A; Shmuelian I; Gazit E
    Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia.
    Mathewson KA; Lindenmayer JP
    J Clin Psychopharmacol; 2007 Dec; 27(6):714-5. PubMed ID: 18004146
    [No Abstract]   [Full Text] [Related]  

  • 24. Agranulocytosis: incidence and risk factors.
    Alvir JM; Lieberman JA
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():137-8. PubMed ID: 7961558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L; Cazard F
    Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hematologic effects of clozapine: evaluation of the international experience].
    Lamarque V
    Encephale; 1995 Jun; 21 Spec No 3():59-60. PubMed ID: 7628344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haematological toxicity of clozapine and some other drugs used in psychiatry.
    Nooijen PM; Carvalho F; Flanagan RJ
    Hum Psychopharmacol; 2011 Mar; 26(2):112-9. PubMed ID: 21416507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [When to continue or stop Clozapine therapy?].
    Jalenques I; Coudert AJ
    Encephale; 1992 Sep; 18 Spec No 3():437-40. PubMed ID: 1339760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report.
    Barnas C; Zwierzina H; Hummer M; Sperner-Unterweger B; Stern A; Fleischhacker WW
    J Clin Psychiatry; 1992 Jul; 53(7):245-7. PubMed ID: 1639744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuing clozapine treatment despite neutropenia.
    Esposito D; Rouillon F; Limosin F
    Eur J Clin Pharmacol; 2005 Jan; 60(11):759-64. PubMed ID: 15660271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood dyscrasias induced by psychotropic drugs.
    Stübner S; Grohmann R; Engel R; Bandelow B; Ludwig WD; Wagner G; Müller-Oerlinghausen B; Möller HJ; Hippius H; Rüther E
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S70-8. PubMed ID: 15052517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clozapine treatment after agranulocytosis induced by classic neuroleptics.
    Bauer M; Mackert A
    J Clin Psychopharmacol; 1994 Feb; 14(1):71-3. PubMed ID: 7908676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies.
    Zipris P; Melamed Y; Weizman A; Bleich A
    Isr J Psychiatry Relat Sci; 2007; 44(1):54-6. PubMed ID: 17665812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine-induced neutropenia in children: management with lithium carbonate.
    Sporn A; Gogtay N; Ortiz-Aguayo R; Alfaro C; Tossell J; Lenane M; Gochman P; Rapoport JL
    J Child Adolesc Psychopharmacol; 2003; 13(3):401-4. PubMed ID: 14642024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian rhythm of white blood cells during clozapine treatment.
    Ahokas A; Elonen E
    Psychopharmacology (Berl); 1999 Jun; 144(3):301-2. PubMed ID: 10435399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High risk of eosinophilia in women treated with clozapine.
    Banov MD; Tohen M; Friedberg J
    J Clin Psychiatry; 1993 Dec; 54(12):466-9. PubMed ID: 8276737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethnic neutropenia and clozapine.
    Bray A
    Aust N Z J Psychiatry; 2008 Apr; 42(4):342-5. PubMed ID: 18330777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased apoptosis of neutrophils in a case of clozapine-induced agranulocytosis - a case report.
    Loeffler S; Fehsel K; Henning U; Fischer J; Agelink M; Kolb-Bachofen V; Klimke A
    Pharmacopsychiatry; 2003 Jan; 36(1):37-41. PubMed ID: 12649775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eosinophilia associated with decreasing neutrophil count in a clozapine-treated patient.
    Galletly C; Wilson D; McEwen S
    J Clin Psychiatry; 1996 Jan; 57(1):40-1. PubMed ID: 8543549
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hematologic effects of clozapine: a review of the international experience].
    Lamarque V
    Encephale; 1996 Dec; 22 Spec No 6():35-6. PubMed ID: 9102319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.